RIVANNA® Appoints Jacob Katz Senior Director of Sales and Product Management

Experienced healthcare marketing expert leads business strategy and growth

CHARLOTTESVILLE, Va., July 20, 2022 (GLOBE NEWSWIRE) — RIVANNA®, developers of leading imaging-based medical solutions, has appointed Jacob Katz as senior director of sales and product management. Katz is responsible for strategic marketing planning, go-to-market management and driving market adoption. Additionally, he works to optimize distribution partnerships and inform product development strategy through customer insights.

Prior to joining RIVANNA, Katz was Director of Marketing Strategy for Medline Industries, Inc. In this role, he led multi-channel marketing strategy for a product portfolio exceeding 40 brands, including brands generating over $100 million in revenue. income. Katz also served as a product manager for Medline, during which time he tripled sales of advanced wound treatments in less than 10 years.

Katz holds an MBA from the Kellogg Graduate School of Management at Northwestern University, where he graduated with honors.

“I am impressed with RIVANNA’s impactful technology, brilliant management team and excellent product development pipeline,” comments Katz. “I am delighted to help RIVANNA achieve its potential in terms of financial performance and clinical impact.”

RIVANNA has innovative products in development that address multi-billion dollar market segments. These include a rapid, radiation-free fracture detection system developed in partnership with the Biomedical Advanced Research and Development Authority and an automated 3D image-guided system designed to relieve chronic pain in a safe and effective without the need for addictive opioids.

“We salute Jacob’s significant experience in sales, strategic marketing, and product management as we move forward with the commercialization and deployment of our new technologies,” comments Will Mauldin, PhD, co-founder and CEO of RIVANNA. “Jacob combines a wealth of successful medical device commercialization experience with a strong business background from a highly regarded MBA program. We are delighted to have him on our team.”


RIVANNA® is a commercial-stage medical device innovator and manufacturer in Charlottesville, Virginia. RIVANNA’s mission is to develop and commercialize the first imaging-based medical technologies that elevate global standards of care. RIVANNA’s technology platform combines the advantages of ultrasound with the bone imaging capabilities of X-rays to address unmet clinical needs. BoneVision™ and BoneEnhance® optimize ultrasound image acquisition and visualization to provide radiation-free alternatives to X-ray imaging. When combined with SpineNav3D™ AI-enabled image recognition, the platform provides comprehensive clinician support that improves decision-making, clinician workflows, health outcomes and patient satisfaction. The company operates an FDA registered and ISO 13485:2016 certified manufacturing facility where it produces the Accuro® product line and associated medical equipment and components. For more information, visit rivannamedical.com.

For media inquiries, please contact [email protected]

This content was posted through the press release distribution service on Newswire.com.